Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Country/Region as subject
Language
Affiliation country
Publication year range
1.
Nutrients ; 13(10)2021 Sep 27.
Article in English | MEDLINE | ID: mdl-34684408

ABSTRACT

We previously showed that supplementation of a high fat diet with paramylon (PM) reduces the postprandial glucose rise, serum total and LDL cholesterol levels, and abdominal fat accumulation in mice. The purpose of this study was to explore the underlying mechanism of PM using microarray analysis. Male mice (C57BL/BL strain) were fed an experimental diet (50% fat energy) containing 5% PM isolated from Euglena gracilis EOD-1 for 12 weeks. After confirming that PM had an improving effect on lipid metabolism, we assessed ileal and hepatic mRNA expression using DNA microarray and subsequent analysis by gene ontology (GO) classification and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis. The results suggested that dietary supplementation with PM resulted in decreased abdominal fat accumulation and serum LDL cholesterol concentrations via suppression of the digestion and absorption pathway in the ileum and activation of the hepatic PPAR signaling pathway. Postprandial glucose rise was reduced in mice fed PM, whereas changes in the glucose metabolism pathway were not detected in GO classification and KEGG pathway analysis. PM intake might enhance serum secretory immunoglobulin A concentrations via promotion of the immunoglobulin production pathway in the ileum.


Subject(s)
Dietary Supplements , Glucans/administration & dosage , Ileum/metabolism , Lipid Metabolism , Liver/metabolism , Obesity/metabolism , Abdominal Fat/metabolism , Animals , Blood Glucose/metabolism , Body Weight , Diet , Eating , Euglena gracilis/chemistry , Gene Expression Regulation , Gene Ontology , Glucans/chemistry , Glucans/isolation & purification , Glucans/pharmacology , Immunoglobulin A, Secretory/blood , Lipids/blood , Male , Metabolic Networks and Pathways/genetics , Mice , Mice, Inbred C57BL , Oligonucleotide Array Sequence Analysis , Organ Size , RNA, Messenger/genetics , RNA, Messenger/metabolism , Signal Transduction/genetics
2.
Mar Drugs ; 19(7)2021 Jun 22.
Article in English | MEDLINE | ID: mdl-34206160

ABSTRACT

To investigate whether supplementation with iodine-reduced kelp (Laminaria japonica) powder decreases body fat composition in overweight Japanese subjects, a randomized, double-blind, placebo-controlled intervention study was conducted in 50 Japanese subjects with body mass index (BMI) ≥25 and <30 kg/m2. Subjects were randomly assigned to consume thirty tablets/d (10 tablets orally, 3 times/d) containing either iodine-reduced kelp powder (test, 6 g kelp powder corresponding to 3 g alginate/d) or kelp-free powder (placebo) for 8 weeks. Anthropometric measurements, blood lipids, and serum thyroid hormone levels were obtained before and after the trial. Body fat percentage was significantly decreased in male subjects from the test group compared with the placebo group. The same tendency was observed for body weight (p = 0.065) and BMI (p = 0.072) in male subjects. No significant changes in anthropometric measurements or visceral fat area were observed in female subjects. Serum thyroid hormone concentrations did not increase after 1.03 mg/d of iodine supplementation through kelp intake. The intake of iodine-reduced kelp powder led to significant and safe reductions in body fat percentage in overweight male subjects. The consumption of kelp high in alginate may contribute to preventing obesity without influencing thyroid function in Japanese subjects with a relatively high intake of iodine from seaweed.


Subject(s)
Dietary Supplements , Kelp , Obesity/drug therapy , Adult , Anthropometry , Aquatic Organisms , Body Mass Index , Double-Blind Method , Female , Humans , Japan , Lipids/blood , Male , Middle Aged , Phytotherapy , Thyroid Hormones/blood , Treatment Outcome , Young Adult
3.
PLoS One ; 14(6): e0218118, 2019.
Article in English | MEDLINE | ID: mdl-31185060

ABSTRACT

We investigated whether supplementation with the barley line BARLEYmax (Tantangara; BM), which contains three fermentable fibers (fructan, ß-glucan, and resistant starch), modifies the microbiota in cecal and distal colonic digesta in addition to short-chain fatty acids (SCFAs) production more favorably than supplementation with a high-ß-glucan barley line (BG012; BG). Male Sprague-Dawley rats were randomly divided into 3 groups that were fed an AIN-93G-based diet that contained 5% fiber provided by cellulose (control), BM or BG. Four weeks after starting the respective diets, the animals were sacrificed and digesta from the cecum, proximal colon and distal colon were collected and the SCFA concentrations were quantified. Microbiota in the cecal and distal colonic digesta were analyzed by 16S rRNA sequencing. The concentrations of acetate and n-butyrate in cecal digesta were significantly higher in the BM and BG groups than in the control group, whereas the concentration of total SCFAs in cecal digesta was significantly higher only in the BM group than in the control group. The concentrations of acetate and total SCFAs in the distal colonic digesta were significantly higher only in the BM group than in the control group. The abundance of Bacteroidetes in cecal digesta was significantly higher in the BM group than in the control group. In contrast, the abundance of Firmicutes in cecal digesta was significantly lower in the BM and BG groups than in the control group. These results indicated that BM increased the concentration of total SCFAs in the distal colonic digesta. These changes might have been caused by fructan and resistant starch in addition to ß-glucan. In conclusion, fermentable fibers in BM reached the distal colon and modified the microbiota, leading to an increase in the concentration of total SCFAs in the distal colonic digesta, more effectively compared with the high-ß-glucan barley line (BG).


Subject(s)
Bacteroidetes/metabolism , Cecum/microbiology , Colon/microbiology , Fatty Acids/biosynthesis , Hordeum , Microbiota/drug effects , beta-Glucans/pharmacology , Animal Feed , Animals , Rats , Rats, Sprague-Dawley
SELECTION OF CITATIONS
SEARCH DETAIL